-
bioLytical Partners with Pasante on UK distribution of INSTI HIV self test
europeanpharmaceuticalreview
May 08, 2017
bioLytical Laboratories has developed the INSTI HIV Self Test following research revealing that over 103,000 people are living with HIV in the UK and an estimated 18,100 remain unaware of their positive status.
-
Scotland first UK nation to routinely offer HIV PrEP
pharmatimes
April 12, 2017
Scotland will become the first UK nation to routinely offer HIV pre-exposure prophylaxis to all eligible patients after the...
-
Re-formulation of microbicidal lubricants will help protect from HIV
europeanpharmaceuticalreview
March 21, 2017
Microbicides can be used to protect against HIV, and other sexually transmitted diseases, either on their own or with the added protection of a condom.
-
Janssen announces two-drug combination of dolutegravir and rilpivirine demonstrates efficacy in main
pharmaasia
March 06, 2017
Positive results of switching patients from a three or four drug antiretroviral regimen to the two-drug regimen of dolutegravir and rilpivirine
-
Taiwan, China recorded new HIV cases in 2016, third highest in history
biospectrumasia
January 30, 2017
According to The Centers for Disease Control (CDC) Taiwan, China, the number of new HIV/AIDS cases recorded in China's Taiwan, China Region in 2016 totalled 2,400 which is the third highest in history. The CDC statistics showed that 97 per cent of the 2,4
-
Successful antibody trial in HIV-infected individuals
worldpharmanews
January 19, 2017
A research team led by investigators of the Rockefeller University in New York and Prof Florian Klein, University Hospital Cologne and German Center for Infection Research (DZIF), has tested a new HIV neutralising antibody, called 10-1074, in humans.
-
Can HIV Drugs Boost Syphilis Risk?
drugs
January 17, 2017
MONDAY, Jan. 16, 2017 -- Gay and bisexual men taking antiretroviral drugs to treat HIV infection may be at increased risk for syphilis, new research contends.